Dup(3) (p23p25) syndrome and array-based comparative genomic hybridization  by Weng, Chun-Ying et al.
at SciVerse ScienceDirect
Tzu Chi Medical Journal 24 (2012) 90e91Contents lists availableTzu Chi Medical Journal
journal homepage: www.tzuchimedjnl .comClinical Practice and Therapeutics
Dup(3) (p23p25) syndrome and array-based comparative genomic hybridization
Chun-Ying Weng a, Peng-Yeong Woon b, Pei-Chun Lai a, Yu-Hsun Chang a, Tzu-Ying Li a, Yi-Ning Su c,
Jye-Siung Fang b, Shao-Yin Chu a,d,*
aDepartment of Pediatrics, Buddhist Tzu Chi General Hospital, Hualien, Taiwan
bDepartment of Molecular Biology and Human Genetics, Tzu Chi University, Hualien, Taiwan
cDepartment of Medical Genetics, National Taiwan University Hospital, Taipei, Taiwan
dDepartment of Medical Education, Buddhist Tzu Chi General Hospital, Hualien, Taiwana r t i c l e i n f o
Article history:
Received 1 August 2011
Received in revised form
20 September 2011
Accepted 3 October 2011* Corresponding author. Department of Pediatrics
Hospital, 707, Section 3, Chung-Yang Road, Hu
38561825x3649; fax: þ886 38563532.
E-mail address: chu_chu@tzuchi.com.tw (S.-Y. Chu
1016-3190/$ e see front matter Copyright  2012, Bu
doi:10.1016/j.tcmj.2011.12.001A high resolution peripheral blood G-banded chromosome
study was arranged for a 3-month-old female infant due to the
presence of multiple congenital anomalies (MCA), including: ﬂat
face, ﬂat occiput, ﬂat nasal bridge, retrognathia, ﬁsh mouth, low set
and dysplastic ears, temporal narrowing, short neck and prominent
nuchal fold, and clinodactyly and hypoplastic toe nails (Fig. 1). Soon
after birth, the infant was found to have mild whole body edema
with hypoalbuminemia of an unknown cause and congenital heart
disease, which included patent ductus arteriosus (PDA) and
tricuspid regurgitation. No evidence of congestive heart failure or
PDA persisted after two doses of oral indomethacin. Preterm labor
had not occurred and the infant’s birth weight was 3.2 kg. During
follow-up at an outpatient clinic, weak crying, extended daytime
sleeping, and delayed developmental milestones were noted by the
early infant developmental screening program.
Karyotyping revealed 46,XX, dup(3) (p23p25) (20 cells);
a surprising de novo chromosomal aberration due to the fact that
parental peripheral blood chromosome studies were normal. No
similar chromosomal anomaly has been identiﬁed in Taiwan or
in the scientiﬁc literature. Chromosomal microarray (CMA) by
array-based comparative genomic hybridization (aCGH) was
carried out in order to determine copy number of the chromosomal
aberration and revealed: arr 3p26.3p24.2 (RP11-63O1/RP11-
1149N13) 3 (Fig. 2).
In 2010, consensus was that CMA is a ﬁrst-tier clinical diagnosis
method for patients affected by multiple congenital anomalies,, Buddhist Tzu Chi General
alien, Taiwan. Tel.: þ886
).
ddhist Compassion Relief Tzu Chiautism spectrum disorder, unexplained developmental delay, or
intellectual disability because CMA has greater sensitivity when
detecting submicroscopic deletions or duplications. The density of
aCGH is sufﬁcient to allow detection of copy number changes
around 1 Mega base-pair (Mbp). This should be compared to
G-banded karyotyping which detects genomic imbalances in the
range of 5e10 Mbp on occasion. CMA represents a greater than
10-fold improvement in resolution and narrows down potential
indications from G-banded karyotyping to obvious chromosomal
diseases, e.g. Down syndrome, especially when there is a family
history of chromosomal rearrangement or a history of multiple
miscarriages.
As part of the patient’s clinical care and with the parents’
informed consent, there were clear indications that supported
carrying out aCGH, making it possible to pinpoint the more precise
genomic variations. Nonetheless, issues associated with chromo-
somal variations of uncertain clinical signiﬁcance are still present.
The fact that there are no uniform guidelines for determining the
clinical signiﬁcance of genetic variation identiﬁed by aCGH poses
a challenge. In this context, poor correlation betweenphenotype and
genotype remains a major issue that needs to be explored. In many
cases, the beneﬁts of CMA do not yet directly affect the patient.Further reading
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Fig. 2. (A) Karyotype result: 46,XX, dup(3) (p23p25). Double arrow indicates the duplication area. (B) Array-based comparative genomic hybridization result (circled) from 3p26 to
3p24.2 (2495414/16469054), which shows the presence of a 14 MB gene duplication.
Fig. 1. Dup(3) (p23p25) syndrome. (A) Flat face, full cheeks, ﬁsh mouth, ﬂat nasal bridge, hypertelorism, temporal narrowing. (B) Flat occiput, retrognathia, low set dysplastic ears.
(C) Prominent nuchal fold, short neck. (D, E) Overlapping ﬁngers. (F) Prominent toetip pads. (G) Hypoplastic toenail (published with the parents' consent).
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